查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439898

血小板聚集设备 - 全球市场回顾、竞争格局、市场预测(2030)

Platelet Aggregation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球血小板聚集设备市场规模将于2023年达到3.6554亿美元，2030年将达到5.7325亿美元，预计2024-2030年期间复合年增长率为7.85%。 由于心血管疾病、血液疾病和其他针对性疾病盛行率上升，以及全球老年人口负担迅速增加等多种因素，该市场正呈现正成长。 此外，血小板聚集仪技术的进步，例如血小板的精确自动化测试，将在未来几年增加对该设备的需求。 此外，医疗产业产学合作和临床研究的增加也将有助于血小板聚集设备市场的成长。 此外，全球监管机构批准和上市的增加将进一步促进血小板聚集设备市场的整体成长。 因此，预计在 2024-2030 年预测期内，血小板聚集设备市场将以显着的复合年增长率成长。

血小板聚集装置市场动态

血小板聚集设备市场的主要驱动因素之一是出血和血液疾病的增加。

例如，国家罕见疾病组织 (NORD) 在最近的一项研究中指出，美国成年人中免疫性血小板减少症 (ITP) 的盛行率估计为每年每 10 万人中 3.3 例。 此外，据报导 ITP 盛行率为每 10 万人 9.5 人。 此外，马里兰州卫生保健委员会的一项调查(2023)发现，2022年美国1至5岁儿童ITP盛行率为每10万中9.5例，6至10岁儿童每10万中7.3例，据估计，每10 万名11 岁至14 岁的人中就有4.1 人患有此病。

免疫性血小板减少症(ITP)是血小板疾病的一种，可以藉助血小板聚集装置进行诊断。 因此，ITP数量的增加将增加诊断测试，最终增加对血小板聚集设备市场的需求。

此外，其他出血和血小板疾病的日益普及将推动血小板聚集设备市场的发展。 例如，伯纳德苏利尔症候群是一种罕见的出血性疾病，影响男性和女性的人数相同。 NORD 最近的一项研究估计，每 100 万人中就有 1 人患有 Bernard Soulier 综合征。 2022 年，全球报告了 200 多例病例。 可以使用血小板聚集装置来检测此类症候群。

此外，对血小板聚集系统的需求主要源于瞭解血小板与血管表面相互作用机制的研究，以及瞭解抗血小板药物新靶点的抗血栓因子的评估和筛选。在学术机构和製药公司。 因此，不断增加的研发活动和临床试验将推动未来几年市场对该设备的需求。

因此，在 2024-2030 年预测期内，上述因素将共同推动整个血小板聚集设备市场的发展。

然而，产品供应量下降、缺乏训练有素且技术熟练的专业人员以及程序限制可能会阻碍全球血小板聚集设备市场的成长。

COVID-19 大流行对血小板聚集设备市场产生了负面影响。 疫情的爆发导致门诊取消，并暂停了针对癌症、糖尿病和心血管疾病等慢性疾病的非急诊医院和外科手术。 此外，由于优先考虑 COVID-19 检测，许多疾病的诊断检测有所减少。 此外，由于严格的封锁规定，该设备的生产已停止。 然而，随着封锁规定的放鬆和经济状况的正常化，COVID-19 疫苗的开发将创造一个经济復苏的过程，增加对常规医疗服务、诊断测试和手术程序的需求，以治疗和管理各种疾病。开始恢復手术进程，导致血小板聚集设备市场需求增加，使血小板聚集设备市场的设备需求重回正轨。

本报告研究和分析了全球血小板聚集设备市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第1章血小板聚集设备市场报告简介

第2章血小板聚集设备市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估

第3章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章血小板聚集仪市场主要因素分析

  • 推动血小板聚集设备市场的因素
    • 心血管疾病、血液疾病和其他目标疾病的盛行率不断上升
    • 人口老化负担激增
    • 血小板聚集仪技术的进步
    • 加强产学合作与临床研究
  • 血小板聚集设备市场的抑制因素与挑战
    • 产品供应量减少
    • 缺乏训练有素、技术熟练的专业人员
    • 治疗限制
  • 血小板聚集装置的市场机会
    • 诊断实验室采用自动化系统并提高市场偏好
    • 结合床边护理与小型血小板聚集仪

第5章血小板聚集设备市场波特五力分析

第6章COVID-19对血小板聚集设备市场的影响分析

第7章血小板聚集装置市场布局

  • 依产品类型
    • 系统
    • 试剂
    • 消耗品和配件
  • 依用途
    • 临床应用
    • 研究用途
  • 按最终用户
    • 医院
    • 诊断实验室
    • 其他
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第 8 章血小板聚集装置市场：全球公司占有率分析 - 3 至 5 家主要公司

第9章血小板聚集装置市场公司及产品概况

  • F. Hoffmann-La Roche Ltd
  • Werfen
  • Drucker Diagnostics
  • Haemonetics Corporation
  • Sienco, Inc.
  • BIO/DATA CORPORATION
  • AggreDYNE
  • Siemens Healthcare Private Limited
  • Chrono-log Corporation
  • Grifols, S.A.
  • Helena Laboratories Corporation.
  • SENTINEL.
  • Sysmex Corporation
  • Matis Medical Inc.
  • Behnk Elektronik GmbH & Co.

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

Product Code: DIMDCL0575

Platelet Aggregation Devices Market By Product Type (Systems, Reagents, And Consumables & Accessories), By Application (Clinical Applications And Research Applications), By End-User (Hospitals, Diagnostic Laboratories, And Others) and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing number of target disorders and increasing number of research and clinical studies worldwide

The global platelet aggregation devices market was valued at USD 365.54 million in 2023, growing at a CAGR of 7.85% during the forecast period from 2024 to 2030 to reach USD 573.25 million by 2030. The platelet aggregation devices market is witnessing positive growth owing to various factors such as the rising prevalence of cardiovascular, hematological, and other target disorders and surging burden of geriatric population across the globe. Further, technological advancements in platelet aggregometers, for instance accurate and automatic testing of platelets and other advancements will increase the demand of the device in the forthcoming years. Additionally, the rise in the number of industry-academia collaborations and clinical studies in the healthcare industry will also contribute in the growth of platelet aggregation devices market. Also, the increasing regulatory approvals and launches across the globe will further increase the overall growth of the platelet aggregation devices market. Therefore, the market for platelet aggregation devices market is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Platelet Aggregation Devices Market Dynamics:

One of the main driver for the platelet aggregation devices market is the increasing figures of bleeding and haematological disorders.

For instance, the National Organization for Rare Disorders (NORD) stated in a latest study the incidence of adult Immune thrombocytopenia (ITP) in the United States was roughly estimated to be 3.3 per 100,000/year. Also, the prevalence od ITP was reported to be 9.5 per 100,000. Further, in a study done by the Maryland Health Care Commission (2023), the prevalence of ITP was estimated to be 9.5 per 100,000 children ages 1-5, 7.3 per 100,000 in children ages 6-10, and 4.1 per 100,000 in children of ages 11-14, in 2022, in the United States.

Immune thrombocytopenia (ITP) is a type of platelet disorder, whose diagnosis can be done with the help of platelet aggregation devices market. Thus, the increasing figures of ITP will increase the number of diagnosis test, ultimately rising the demand of the platelet aggregation devices market.

Further, increasing incidence of other bleeding and platelet disorder will drive the market of platelet aggregation devices market. For instance, Bernard-Soulier syndrome is a rare bleeding disorder that affects males and females in equal numbers. Recent study done by NORD suggests that Bernard Soulier syndrome affects 1 in a million people. More than 200 cases have been reported in 2022, worldwide. The detection of such syndromes can be done using platelet aggregation devices market.

Additionally, the demand for platelet aggregation systems is increasing in academic and pharmaceutical companies due to the increase in research studies, mainly to know the mechanisms involved in the interaction of platelets with vascular surfaces and evaluation and screening anti-thrombotic factors to know new targets for antiplatelet drugs. Thus, the increasing research & developmental activities and clinical trials will propel the demand of the device in the market in upcoming years.

Therefore, the factors stated above collectively will drive the overall market of platelet aggregation devices market during the forecast period from 2024-2030.

However, reduced product availability, lack of trained and skilled professionals, procedural limitations, and others, can hinder the global platelet aggregation devices market growth.

The COVID-19 pandemic has negatively impacted the market for platelet aggregation devices market. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and surgical procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, and others. Moreover, the number of diagnostic tests many disorders were reduced as the priority was given to the covid-19 testing. Further, due to imposition of strict lockdown rules the manufacturing of the devices was ceased. However, vaccine development of COVID-19 has produced the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services, diagnostic tests, and surgical procedures for the treatment and management of various diseases ultimately increasing the demand of platelet aggregation devices market, thereby bringing the demand for device on track in the platelet aggregation devices market.

Platelet Aggregation Devices Market Segment Analysis:

Platelet aggregation devices market by Product Type (Systems, Reagents, and Consumables & Accessories), Application (Clinical Applications and Research Applications), End-User (Hospitals, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the platelet aggregation devices market, the systems market is expected to have a significant revenue share in the year 2023. This was primarily owing to the application of the segment. Moreover, the advantages such as accuracy, portability, and others offered by the systems along with the increasing product launches in the market will spur the demand of the segment in the upcoming years.

The systems are specifically designed to support diagnoses of hemostasis disorders including von Willebrand Disease (vWD), Glanzmann's disease, HIT, Bernard Soulier Syndrome, Sticky Platelet Syndrome, and others. The platelet aggregation systems can also be used to precisely monitor the use of anti-platelet drugs during clinical trials or patient therapy. Moreover, the system measures the rate and extent of aggregation, agglutination, activation and inhibition reactions. Thus, the increasing prevalence of any of the above disorder can propel the demand of systems segment in the forecast period.

Further, the automated platelet aggregometry systems offer various advantages such as accuracy, reduced platelet-rich plasma volume and time, simultaneous assay and test conduction, and other advantages will increase its demand in the market.

The rising regulatory activities and launches will in turn propel the demand of the systems in the market, thereby propelling the overall growth of platelet aggregation devices market. For instance, in March 2020, Hart Bio launched ADP MEA and TRAP-6 MEA, designed to monitor and test the platelet aggregation function of patients. Both ADP MEA and TRAP-6 MEA are designed to monitor and test the platelet aggregation function of patients.

Thus, the above-mentioned factors will in turn drive the systems segment market in platelet aggregation devices market, thereby propelling the overall market growth of platelet aggregation devices market in the forecast period from 2022 - 2028.

North America is expected to dominate the overall Platelet Aggregation Devices Market:

Among all the regions, North America is expected to dominate the global platelet aggregation devices market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing number of target disorders, increasing geriatric population, technological advancements in platelet aggregometer, rising awareness among healthcare professionals regarding the benefits offered by platelet aggregation testing in disease diagnosis, and others will increase the demand for platelet aggregation devices market in North America, leading to a rise in the overall platelet aggregation devices market growth.

For instance, as per a report provided by Centers for Disease Control (CDC) in 2022, every 40 seconds, an American may have a heart attack. Platelet function tests using platelet aggregation devices market are used to monitor the antiplatelet drugs as a means to predict in cardiovascular disease. Thus, increasing prevalence of cardiovascular disorders in the North America will increase the number of platelet function test, thus leading to a higher demand for platelet aggregation devices market, which will drive the market in the North America.

Further, the increasing prevalence of bleeding and hematological disorders will shoot the demand of the device. According to the World Federation of Hemophilia 2022 report, there were about 14,816 patients with hemophilia including (Hemophilia A -11,790 and Hemophilia B-3,026) in the United States in 2020 and 3,924 patients with hemophilia in Canada in 2020 including (Hemophilia A -3,223 and Hemophilia B-701). Therefore, platelet aggregation testing is found to be very beneficial in disease diagnosis.

Additionally, factors such as the rising number of surgical procedures in this country, a large number of the population undergoing cardiovascular surgeries, increasing prevalence of orthopedic, bleeding, and urological disorders are creating high growth opportunities for the market players in the North America.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the platelet aggregation devices market.

Platelet Aggregation Devices Market Key Players:

Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL., Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.

Recent Developmental Activities in the Platelet Aggregation Devices Market:

In July 2022, Sysmex Corporation, a leading name in the global platelet aggregation devices marketplace, announced the launch of new automated blood coagulation analyzers. CN-3500 and CN-6500 are capable of measuring platelet aggregation parameters and blood coagulation in hemostasis and thrombosis fields.

In December 2020, Basking Biosciences Inc., a private biopharmaceutical organization, announced that it had successfully raised US$ 5.4 million in a seed financing round. The company was working on exploring the role of vWF, a redundant mediator of platelet adhesion and aggregation, to develop a reversible thrombolytic therapy for acute ischemic stroke. Rising outbreaks of dengue & malaria and growing incidence of blood cancer are also expected to drive platelet aggregation system demand in this region.

In April 2019, Aggredyne Inc. received the US FDA approval for AggreGuide A-100 ADP assay testing cartridge, an in vitro diagnostic device used for measuring various antiplatelet medications that target the platelet P2Y12 receptor.

Key Takeaways from the Platelet Aggregation Devices Market Report Study

  • Market size analysis for current platelet aggregation devices market (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the platelet aggregation devices market
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
  • Key companies dominating the global platelet aggregation devices market
  • Various opportunities are available for the other competitor in the platelet aggregation devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current platelet aggregation devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for platelet aggregation devices market growth in the coming future?

Target Audience who can be benefited from this Platelet Aggregation Devices Market Report Study

  • Platelet aggregation devices market providers
  • Research organizations and consulting companies
  • Platelet aggregation devices market -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in platelet aggregation devices market
  • Various end-users who want to know more about the platelet aggregation devices market and the latest technological developments in the platelet aggregation devices market

Frequently Asked Questions for Platelet Aggregation Devices Market:

1. What are platelet aggregation devices market?

Platelet aggregation is the procedure in which the platelets are clomped together in the blood which leads to the formation of a thrombus or clot. The devices involved in the aggregation of platelets are termed as platelet aggregation devices market. The aggrometers, one of the medical device used in platelet aggregation, works against the clotting, to further stop the clot formation. This process is used for the diagnosis and identification of the defects in platelet functions.

2. What is the market for Platelet aggregation devices market?

The global platelet aggregation devices market was valued at USD 365.54 million in 2023, growing at a CAGR of 7.85% during the forecast period from 2024 to 2030 to reach USD 573.25 million by 2030.

3. What are the drivers for the platelet aggregation devices market?

The platelet aggregation devices market is observing an affirmative market growth owing to the factors such as rising prevalence of cardiovascular, haematological, and other target disorders, surging burden of geriatric population, technological advancements in platelet aggregometers, rise in the number of industry-academia collaborations and clinical studies, and the upsurge in the regulatory approvals for platelet aggregation devices market.

4. Who are the key players operating in the platelet aggregation devices market?

Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL., Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.

5. Which region has the highest share in platelet aggregation devices market?

North America is expected to dominate the global platelet aggregation devices market. Factors contributing to the growth are the rising number of cardiovascular surgeries, rising number of orthopaedic, urological, bleeding, and disorders, escalating burden of geriatric patients, and others which are contributing to the growth of the platelet aggregation devices market in the North America region.

Table of Contents

1.Platelet aggregation devices market Report Introduction

2.Platelet aggregation devices market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The US
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Platelet aggregation devices market Key Factors Analysis

  • 4.1. Platelet aggregation devices market Drivers
    • 4.1.1. Rising prevalence of cardiovascular, hematological, and other target disorders
    • 4.1.2. Surging burden of geriatric population
    • 4.1.3. Technological advancements in platelet aggregometers
    • 4.1.4. Rise in the number of industry-academia collaborations and clinical studies
  • 4.2. Platelet aggregation devices market Restraints And Challenges
    • 4.2.1. Reduced product availability
    • 4.2.2. Lack of trained and skilled professionals
    • 4.2.3. Procedural limitations
  • 4.3. Platelet aggregation devices market Opportunities
    • 4.3.1. Growing adoption and market preference for automated systems among diagnostic laboratories
    • 4.3.2. Incorporation of point-of-care and miniaturized platelet aggregometers

5. Platelet aggregation devices market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Platelet aggregation devices market

7. Platelet aggregation devices market Layout

  • 7.1. By Product Type
    • 7.1.1. Systems
    • 7.1.2. Reagents
    • 7.1.3. Consumables and Accessories
  • 7.2. By Application
    • 7.2.1. Clinical Applications
    • 7.2.2. Research Applications
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Laboratories
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.1.3. Mexico Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.2. Germany Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.3. United Kingdom Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.4. Italy Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.5. Spain Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.6. Russia Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.7. Rest of Europe Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1. China Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.2. Japan Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.3. India Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.4. Australia Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.5. South Korea Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.6. Rest of Asia Pacific Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.4.2. Africa Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.4.3. South America Platelet aggregation devices market Size in USD Million (2021-2030)

8. Platelet aggregation devices market Global Company Share Analysis - Key 3-5 Companies

9. Platelet aggregation devices market Company and Product Profiles

  • 9.1. F. Hoffmann-La Roche Ltd
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Werfen
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Drucker Diagnostics
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Haemonetics Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Sienco, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. BIO/DATA CORPORATION
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. AggreDYNE
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Siemens Healthcare Private Limited
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Chrono-log Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Grifols, S.A.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Helena Laboratories Corporation.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. SENTINEL.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Sysmex Corporation
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Matis Medical Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Behnk Elektronik GmbH & Co.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Platelet aggregation devices market in Global (2021-2030)
  • Table 4: Platelet aggregation devices market in Global by Product Type (2021-2030)
  • Table 5: Platelet aggregation devices market in Global by Application (2021-2030)
  • Table 6: Platelet aggregation devices market in Global by End-User (2021-2030)
  • Table 7: Platelet aggregation devices market in Global by Geography (2021-2030)
  • Table 8: Platelet aggregation devices market in North America (2021-2030)
  • Table 9: Platelet aggregation devices market in North America by Country (2021-2030)
  • Table 10: Platelet aggregation devices market in the US (2021-2030)
  • Table 11: Platelet aggregation devices market in Canada (2021-2030)
  • Table 12: Platelet aggregation devices market in Mexico (2021-2030)
  • Table 13: Platelet aggregation devices market in Europe (2021-2030)
  • Table 14: Platelet aggregation devices market in Europe by Country (2021-2030)
  • Table 15: Platelet aggregation devices market in France (2021-2030)
  • Table 16: Platelet aggregation devices market in Germany (2021-2030)
  • Table 17: Platelet aggregation devices market in the United Kingdom (2021-2030)
  • Table 18: Platelet aggregation devices market in Italy (2021-2030)
  • Table 19: Platelet aggregation devices market in Spain (2021-2030)
  • Table 20: Platelet aggregation devices market in Russia (2021-2030)
  • Table 21: Platelet aggregation devices market in Rest of Europe (2021-2030)
  • Table 22: Platelet aggregation devices market in APAC (2021-2030)
  • Table 23: Platelet aggregation devices market in APAC by Country (2021-2030)
  • Table 24: Platelet aggregation devices market in China (2021-2030)
  • Table 25: Platelet aggregation devices market in Japan (2021-2030)
  • Table 26: Platelet aggregation devices market in India (2021-2030)
  • Table 27: Platelet aggregation devices market in Australia (2021-2030)
  • Table 28: Platelet aggregation devices market in South Korea (2021-2030)
  • Table 29: Platelet aggregation devices market in Rest of APAC (2021-2030)
  • Table 30: Platelet aggregation devices market in Rest of World (2021-2030)
  • Table 31: Platelet aggregation devices market in RoW by Region (2021-2030)
  • Table 32: Platelet aggregation devices market in Middle East (2021-2030)
  • Table 33: Platelet aggregation devices market in Africa (2021-2030)
  • Table 34: Platelet aggregation devices market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Platelet aggregation devices market in Global (2021-2030)
  • Figure 4: Platelet aggregation devices market in Global by Product Type (2021-2030)
  • Figure 5: Platelet aggregation devices market in Global by Application (2021-2030)
  • Figure 6: Platelet aggregation devices market in Global by End-User (2021-2030)
  • Figure 7: Platelet aggregation devices market in Global by Geography (2021-2030)
  • Figure 8: Platelet aggregation devices market in North America (2021-2030)
  • Figure 9: Platelet aggregation devices market in North America by Country (2021-2030)
  • Figure 10: Platelet aggregation devices market in the US (2021-2030)
  • Figure 11: Platelet aggregation devices market in Canada (2021-2030)
  • Figure 12: Platelet aggregation devices market in Mexico (2021-2030)
  • Figure 13: Platelet aggregation devices market in Europe (2021-2030)
  • Figure 14: Platelet aggregation devices market in Europe by Country (2021-2030)
  • Figure 15: Platelet aggregation devices market in France (2021-2030)
  • Figure 16: Platelet aggregation devices market in Germany (2021-2030)
  • Figure 17: Platelet aggregation devices market in the United Kingdom (2021-2030)
  • Figure 18: Platelet aggregation devices market in Italy (2021-2030)
  • Figure 19: Platelet aggregation devices market in Spain (2021-2030)
  • Figure 20: Platelet aggregation devices market in Russia (2021-2030)
  • Figure 21: Platelet aggregation devices market in Rest of Europe (2021-2030)
  • Figure 22: Platelet aggregation devices market in APAC (2021-2030)
  • Figure 23: Platelet aggregation devices market in APAC by Country (2021-2030)
  • Figure 24: Platelet aggregation devices market in China (2021-2030)
  • Figure 25: Platelet aggregation devices market in Japan (2021-2030)
  • Figure 26: Platelet aggregation devices market in India (2021-2030)
  • Figure 27: Platelet aggregation devices market in Australia (2021-2030)
  • Figure 28: Platelet aggregation devices market in South Korea (2021-2030)
  • Figure 29: Platelet aggregation devices market in Rest of APAC (2021-2030)
  • Figure 30: Platelet aggregation devices market in Rest of World (2021-2030)
  • Figure 31: Platelet aggregation devices market in RoW by Region (2021-2030)
  • Figure 32: Platelet aggregation devices market in Middle East (2021-2030)
  • Figure 33: Platelet aggregation devices market in Africa (2021-2030)
  • Figure 34: Platelet aggregation devices market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis